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Recent studies combining pharmacological, behavioral, electrophysiological and
molecular approaches indicate that depression results from maladaptive neuroplastic
processes occurring in defined frontolimbic circuits responsible for emotional processing
such as the prefrontal cortex, hippocampus, amygdala and ventral striatum. However,
the exact mechanisms controlling synaptic plasticity that are disrupted to trigger
depressive conditions have not been elucidated. Since glial cells (astrocytes and
microglia) tightly and dynamically interact with synapses, engaging a bi-directional
communication critical for the processing of synaptic information, we now revisit the role
of glial cells in the etiology of depression focusing on a dysfunction of the “quad-partite”
synapse. This interest is supported by the observations that depressive-like conditions
are associated with a decreased density and hypofunction of astrocytes and with
an increased microglia “activation” in frontolimbic regions, which is expected to
contribute for the synaptic dysfunction present in depression. Furthermore, the traditional
culprits of depression (glucocorticoids, biogenic amines, brain-derived neurotrophic
factor, BDNF) affect glia functioning, whereas antidepressant treatments (serotonin-
selective reuptake inhibitors, SSRIs, electroshocks, deep brain stimulation) recover glia
functioning. In this context of a quad-partite synapse, systems modulating glia-synapse
bidirectional communication—such as the purinergic neuromodulation system operated
by adenosine 5′-triphosphate (ATP) and adenosine—emerge as promising candidates
to “re-normalize” synaptic function by combining direct synaptic effects with an ability to
also control astrocyte and microglia function. This proposed triple action of purines to
control aberrant synaptic function illustrates the rationale to consider the interference with
glia dysfunction as a mechanism of action driving the design of future pharmacological
tools to manage depression.
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INTRODUCTION
Depression is the neuropsychiatric disorder with higher incidence worldwide, representing
a major socio-economical burden (Kessler et al., 2003). Depressive conditions display
heterogeneous presentations and are defined clinically based on different affective symptoms
(sadness, desperation, apathy, anhedonia, sensation of discomfort) that decrease interest in daily
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activities (Ferrari et al., 2013). Understanding the causes and
neurobiological basis of depression remains a challenge, probably
due to the lack of faithful animal models (Berton et al.,
2012). The relation between cumulative stress and the incidence
of depression (de Kloet et al., 2005) and the prevalence of
depression in suicide completers (Coryell and Young, 2005),
provide two windows of opportunities to indirectly study the
neurobiological basis of depression using chronically stressed
animals and brain samples from suicide completers.
PURPORTED BIOLOGICAL BASIS
OF DEPRESSION
Depressive conditions have traditionally been considered to
involve a deregulated hypothalamic-pituitary-adrenal (HPA)
axis, leading to an aberrant impact of sustained increased
levels of glucocorticoids (Sousa et al., 2008). However, recent
studies in adrenalectomized animals (thus blunting the main
source of glucocorticoids) revealed an impact of ghrelin
rather than glucocorticoids in formatting the emotional
disturbances associated with repeated stress (Meyer et al.,
2014).
Another lead for the neurobiology of depression is based on
the clinical use of serotonin-selective reuptake inhibitors (SSRIs)
and tricyclic antidepressants (TCAs) to manage depression,
which hints at the dysfunction of the neuromodulation by
serotonin and other biogenic amines in depression (Krishnan
and Nestler, 2008). However, these drugs have a slow onset of
action (over 2 weeks) and are effective in only circa 50% of
patients, leaving open the possibility that they may influence
different targets apart normalizing the levels of biogenic amines.
Neurotrophins and in particular brain-derived neurotrophic
factor (BDNF) have also been linked to depression, based on
the ability of BDNF to reactivate neuronal plasticity and on
the association between serum BDNF levels and depression
(Castrén, 2014). This should be cautiously evaluated since
the plasma levels of substances might not reflect their brain
levels and there is no clear association between depression and
different polymorphisms of the bdnf gene (Gyekis et al., 2013).
Also, excessive BDNF-induced plasticity can actually trigger an
aberrant hyper-plasticity, as heralded by the key pathogenic role
of BDNF in neuropathic pain (Trang et al., 2012).
SYNAPTIC DYSFUNCTION IN
DEPRESSION
A major breakthrough in understanding depression was the
observation that sub-anesthetic doses of ketamine, an NMDA
receptor antagonist, can revert rapidly (within 90min) symptoms
of depression, with a long-lasting antidepressant effect (2 weeks;
Berman et al., 2000; Zarate et al., 2006). Since NMDA receptors
are the main switches to trigger synaptic plasticity (both long-
term potentiation, LTP, and depression, LTD), this indicates that
an abnormal plasticity at glutamatergic synapses underlies the
expression of depressive symptoms (Duman and Aghajanian,
2012); indeed, chronically-stressed rodents display abnormal
patterns of synaptic plasticity (both LTP and/or LTD) in
brain areas involved in emotional processing, namely amygdala,
ventral striatum, hippocampus and prefrontal cortex (Krishnan
and Nestler, 2008). Animal studies also allowed identifying the
molecular mechanisms of the antidepressant effect of ketamine,
which involves the antagonism of NMDA (2B) receptors and
the preservation of dendritic morphology and AMPA receptor
trafficking through an mTOR pathway in the prefrontal cortex
(Li et al., 2010). This joins other observations showing that
riluzole and antagonists of types 2/3 or 5 metabotropic glutamate
receptors, which control glutamatergic transmission, also display
robust antidepressant effects (Machado-Vieira et al., 2009; Pilc
et al., 2013). Altogether these observations support the hypothesis
that depression results from the disruption of mechanisms
controlling synaptic plasticity in afflicted regions (Duman and
Aghajanian, 2012).
This de-regulation seems to translate into a destabilization
and loss of synaptic connections. Indeed, repeated stress triggers
a reduction of dendritic complexity in prefrontocortical and
hippocampal neurons (Magariños et al., 1997; Sousa et al.,
2000; Radley et al., 2006) and a selective loss of markers of
excitatory synapses (Gilabert-Juan et al., 2012; Tzanoulinou et al.,
2014; Kaster et al., 2015), which recover upon alleviation of
‘‘depressive’’-like symptoms using SSRIs, exercise or enriched
environment (Li et al., 2010, 2011; McEwen et al., 2012). Post-
mortem brain samples of depressed patients also revealed a
reduction in the size rather than number of prefrontocortical
and hippocampal pyramidal neurons (Rajkowska et al., 1999;
Stockmeier et al., 2004) accompanied by a decreased number
of synaptic contacts (Kang et al., 2012). As occurs in stressed
rodents, synaptic markers in frontolimbic area are also altered
in patients with major depressive disorder (Feyissa et al., 2009;
Zhao et al., 2012; Duric et al., 2013).
This pivotal role of the disruption of mechanisms controlling
synaptic plasticity for the expression of depressive symptoms
also has the attractive feature to allow bridging the different
traditional explanations for the emergence of depression. In fact,
glucocorticoids are well established to affect synaptic plasticity
and to contribute for synaptic atrophy in several brain regions
(Sousa et al., 2008). Likewise, BDNF is well recognized as a
bolster of synaptic plasticity (Gray et al., 2013) and different
biogenic amines, such as serotonin (Lesch and Waider, 2012),
noradrenaline (Marzo et al., 2009) and dopamine (Tritsch and
Sabatini, 2012) impact on synaptic plasticity in cortical regions.
However, although the pivotal role of aberrant synaptic
plasticity successfully integrates different findings derived from
patients and animal models of depression, it still fails to provide
an explanation for the etiology of depression. This review
proposes to focus on the emerging concept of the quad-partite
synapse (Schafer et al., 2013), integrating both astrocytes and
microglia as critical pillars of synaptic plasticity, to address the
possible relevance of a mis-communication between glia and
synapses, as a possible basis of depression.
THE “QUAD-PARTITE” SYNAPSE
Astrocytes were long considered as morphological and metabolic
support cells, as testified by their importance in the synthesis
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(Rose et al., 2013) and re-uptake of glutamate (Asztely et al.,
1997; Arnth-Jensen et al., 2002), in buffering extracellular
K+ to control neuronal excitability (Wallraff et al., 2006),
in neurovascular coupling (Viswanathan and Freeman, 2007;
Petzold et al., 2008; Figley and Stroman, 2011) and transport
(Rouach et al., 2008) and delivery of nutrients to active synapses
(Magistretti et al., 1999; Pellerin et al., 2007). This concept
has actually evolved to recognize astrocytes as dynamic players
engaged in a bi-directional communication with synapses and
able to actually format synaptic function with impact on the
expression of behavior (Achour and Pascual, 2010; Allen, 2014;
Oliveira et al., 2015). This interplay between synapses and
astrocytes is so tight that it is difficult to disentangle if a synaptic
dysfunction results from intrinsic modifications of neurons or
from astrocytic modifications (Agostinho et al., 2010; Sanacora
and Banasr, 2013; Crunelli et al., 2015; Verkhratsky et al.,
2015).
Probably the first experimental support of an ability of
astrocytes to respond to synaptic activity was provided by
observations that astrocytes respond to glutamate by triggering
a directional long-distance response, typified by a wave of
variation of intracellular calcium (Cornell-Bell et al., 1990). The
inter-astrocytic transport of calcium waves is possible thanks
to the organized formation of a syncytium through different
connexins pores, that form an alphabet still to be fully deciphered
to understand this long-range directional communication of
information through astrocytes (Wallraff et al., 2004; Theis
and Giaume, 2012; Decrock et al., 2015). Astrocytes respond
not only to glutamate, but to most neurotransmitters and
neuromodulators, such as GABA, noradrenaline, acetylcholine
or adenosine 5′-triphosphate (ATP; Volterra and Meldolesi,
2005; Haydon and Carmignoto, 2006). Astrocytic calcium waves
can feedback to influence neuronal responses (Nedergaard, 1994;
Parpura et al., 1994) and control synaptic strength (Jourdain
et al., 2007; Perea and Araque, 2007) through the release of
different mediators such as glutamate, ATP, D-serine, NO,
neurotrophins, prostaglandins or cytokines to name a few
(Volterra and Meldolesi, 2005; Haydon and Carmignoto, 2006).
Several of these mediators are released from astrocytes in a
vesicular manner, with SNARE complexes similar, but with
some differences to neurons (e.g., synaptobrevin 2), able to
sustain a quantal release (Bezzi et al., 2004; Pangrsic et al.,
2007). The relevance of this astrocytic vesicular apparatus to
control synaptic function is re-enforced by the observation that
astrocytic processes enwrap synapses in a spatially organized
manner, with a single astrocyte wrapping from 300 (in rodents)
up to 90,000 (in humans) synapses (Bushong et al., 2002; Ogata
and Kosaka, 2002; Oberheim et al., 2006) and this association
of astrocytes with synapses was found to be an experience-
dependent dynamic process (Genoud et al., 2006; Haber et al.,
2006). This prompted the concept of the tri-partite synapse to
recognize the importance of the astrocytic network as a new
level of integration of information in neuronal networks (Araque
et al., 1999, 2014; Halassa et al., 2007). Accordingly, synaptic
plasticity processes are controlled by different gliotransmitters
such as D-serine (Yang et al., 2003; Panatier et al., 2006;
Henneberger et al., 2010), glutamate (Fellin et al., 2004),
ATP (Koizumi et al., 2003; Zhang et al., 2003; Pankratov and
Lalo, 2015) or adenosine (Newman, 2003; Pascual et al., 2005;
Serrano et al., 2006) or by controlling glutamate clearance
(Diamond, 2001; Tsvetkov et al., 2004; Omrani et al., 2009;
Murphy-Royal et al., 2015). Accordingly, astrocytic function
critically affects integrated brain responses such as sleep, mood or
memory (Banasr and Duman, 2008; Halassa et al., 2009; Suzuki
et al., 2011; Lima et al., 2014; Perea et al., 2014; Matos et al.,
2015).
The addition of microglia to the number of synaptic players
is more recent. Microglia coordinate brain innate immunity,
displaying features characteristic of immune cells able to
rapidly expand their population, to chemotaxically migrate
to sites of injury and to trigger and sustain inflammatory
responses through their chemokine and cytokine repertoire
(Lynch, 2009; Kettenmann et al., 2011). Traditionally, microglia
were considered to be ‘‘resting’’, becoming ‘‘activated’’ upon
allostatic changes to coordinate immune-like responses (Perry
and Gordon, 1988). Several studies revealed that the purported
‘‘resting’’-state of microglia actually corresponds to an active
surveying state, where microglia phylopodia dynamically interact
with neurons and astrocytes with a regulatory and supportive
role critical for brain homeostasis (Raivich, 2005; Hanisch and
Kettenmann, 2007; Wake et al., 2013; Cherry et al., 2014). In
particular, microglia dynamically interact with synapses in an
activity-dependent manner (Biber et al., 2007; Kettenmann et al.,
2013; Wake et al., 2013), to such as extent that the concept of a
quad-partite synapse has been forwarded (Schafer et al., 2013). In
fact, microglia are equipped with receptors for neurotransmitters
(Pocock and Kettenmann, 2007), and excitatory transmission
increases whereas inhibitory transmission decreases microglial
processes dynamic (Fontainhas et al., 2011; Wong et al., 2011).
Conversely, microglia can affect both excitatory and inhibitory
transmission (Tsuda et al., 2003; Pascual et al., 2012) through
the release of a variety of signals ranging from chemokines
(Schafer et al., 2012), cytokines (Rebola et al., 2011), purines
(Pascual et al., 2012; George et al., 2015), glutamate and D-serine
(Scianni et al., 2013), NO (Zhan et al., 2014) or BDNF (Gomes
et al., 2013; Parkhurst et al., 2013). The importance of this
bi-directional communication between synapses and microglia
is best heralded by the synaptic dysfunction observed upon
genetic manipulation of microglia function (Roumier et al.,
2004; Costello et al., 2011; Hoshiko et al., 2012), which can
be direct or involve astrocytes (Pascual et al., 2012). Thus,
microglia are critical for the dynamic synaptic carving that is
essential to entrain adaptive brain function (Paolicelli et al.,
2011; Ji et al., 2013; Cristovão et al., 2014; Zhan et al.,
2014).
DYSFUNCTION OF GLIAL CELLS AND
DEPRESSION
Numerous lines of evidence support the contention that a
modification of astrocytes in frontolimbic regions is associated
with depression (Altshuler et al., 2010; Rajkowska and
Stockmeier, 2013; Peng et al., 2015). Most studies analyzing
post-mortem brain samples from adult individuals with major
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depressive disorder or suicide completers concur to conclude
that there is a decreased number of astrocytic-like elements in
frontolimbic structures (Ongür et al., 1998; Rajkowska et al.,
1999; Cotter et al., 2002; Medina et al., 2015; Nagy et al., 2015;
Torres-Platas et al., 2015). This is paralleled by an alteration
of astrocytic morphology, typified by hypertrophic cell bodies
(Rajkowska et al., 1999; Cotter et al., 2002; Torres-Platas et al.,
2011, 2015), and a modification in frontolimbic regions of
the density of different astrocytic markers, such as GFAP
(Miguel-Hidalgo et al., 2000; Si et al., 2004; Schlicht et al.,
2007; Gittins and Harrison, 2011), connexins (Ernst et al., 2011;
Sun et al., 2012; Miguel-Hidalgo et al., 2014), aquaporin-4
(Rajkowska et al., 2013), GLT-1 and glutamine synthase
(Choudary et al., 2005; Sequeira et al., 2009; Miguel-Hidalgo
et al., 2010) and an increased release of S100β (e.g., Grabe
et al., 2001; Schroeter et al., 2008). A causal relation between
astrocytic dysfunction and depression is provided by animal
studies showing that the selective destruction of frontocortical
astrocytes with the gliotoxin L-α-aminoadipic acid is sufficient
to trigger a depressive-like phenotype (Banasr and Duman,
2008); likewise, a depressive-like phenotype also emerges upon
functional inhibition of astrocytes, such as upon downregulating
synaptobrevin-2 thus blunting astrocytic vesicular release (Cao
et al., 2013), upon altering connexin-mediated gap-junctions
(Sun et al., 2012), upon knocking out IP3-receptor type-2 (Cao
et al., 2013) or aquaporin-4 (Kong et al., 2014) or inhibiting
astrocytic glutamate transporters (Bechtholt-Gompf et al.,
2010; John et al., 2012). Notably, astrocytic function is affected
by the signaling systems assumed as traditional culprits of
depression, namely glucocorticoids (Yin et al., 2013), BDNF
(Ye et al., 2011; Liu et al., 2015), serotonin (Hertz et al., 2015),
noradrenaline (Madrigal et al., 2009; Pankratov and Lalo, 2015)
or dopamine (Shao et al., 2013). Furthermore, treatments
alleviating depressive symptoms can recover astrocytic function,
such as SSRIs (Czéh et al., 2006; Schipke et al., 2011) or
electroconvulsive shock (Iwata et al., 2011) and some are even
critically dependent on astrocytic function, such as fluoxetine
(Kong et al., 2009) or deep brain stimulation (Etiévant et al.,
2015). Altogether, these observations indicate that a decreased
astrocytic function in frontolimbic regions is necessary and
sufficient for the emergence of depressive symptoms (Figure 1).
This suggests a scenario where a defective astrocyte function
FIGURE 1 | Modifications of the quad-partite synapse in depression. The processing of information in synapses is not only defined by neurons, but also by glia
cells, namely by astrocytes, which enwrap synapses, and microglia, which dynamically interact with synapses in an activity-dependent manner (A). Thus, amongst
other roles, astrocytes regulate both K+ and the basal levels of glutamate, defining the basal excitability of neurons; also the extracellular levels of glutamate
contribute to define the density of NMDA and AMPA receptors in the plasma membrane of the post-synaptic compartment, which trigger and sustain alterations of
synaptic plasticity, respectively. The excitability of neurons, their set-up of plasma membrane glutamate receptors, namely of NMDA receptors, and the neurotrophins
support provided by glial cells are critical to allow the implementation of adequate synaptic plasticity traits, i.e., an appropriate encoding of both long-term
potentiation (LTP) and depression (LTD) according to specific patterns of incoming information. In depression (B) there is a modification of information processing in
excitatory synapses in frontolimbic area: there is modification of astrocytes, typified by hypertrophic cell bodies and decreased complexity and activity of phylopodia,
resulting in an hypofunction of astrocytes and a decreased ability to buffer K+ and to clear extracellular glutamate; this leads to increased excitability, corresponding
to greater noise in the circuit, and to an imbalance of NMDA and AMPA receptors, with an increased availability of NMDA receptors in dendrites. Additionally, there is
a decreased signaling through the master chemokine CX3CL1 in microglia, which is associated (through mechanisms still undefined) to a shift of microglia towards a
more pro-inflammatory profile associated with decreased microglia-derived BDNF release. These alterations of the quad-partite synapse, typified by the altered
inter-relations between glial cells and neurons, are associated with an aberrant plasticity, typified by a shift in the stimuli triggering LTD and LTP, which translates into
inadequate encoding of information in frontocortical circuits.
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initially hampers synaptic plasticity, which then evolves into
neuronal loss at advanced phases of depressive disorders.
Depression is also tightly associated with alterations of
microglia and inflammation (Yirmiya et al., 2015; Figure 1).
Thus, depressive patients exhibit increased levels of peripheral
inflammatory markers (Raison et al., 2006; Howren et al., 2009);
conversely, bolstering inflammation triggers a sickness behavior
reminiscent of depression (Dantzer et al., 2008) and patients
with inflammatory and autoimmune diseases often experience
depression (Kiecolt-Glaser et al., 2015). Indeed, most studies
converge to propose thatmicroglia aremorphologically altered in
frontolimbic regions of depressed patients or suicide completers
(Steiner et al., 2008; Schnieder et al., 2014; Torres-Platas et al.,
2014; Setiawan et al., 2015). Likewise, repeated stress in rodents
also triggersmicroglia dystrophy (Kreisel et al., 2014;Milior et al.,
2015; S´lusarczyk et al., 2015) and the manipulation of microglia
function, altering its dynamic (Kreisel et al., 2014) or hampering
microglia-neuron communication via the CX3CR1-fractalkine
pathway (Corona et al., 2010; Milior et al., 2015), alters
stress responsiveness and depressive-like behavior. Furthermore,
microglia function is affected by all the signaling systems
traditionally associated with depression, namely glucocorticoids
(Ros-Bernal et al., 2011), BDNF (Gomes et al., 2013), serotonin
(Müller and Schwarz, 2007; Krabbe et al., 2012), noradrenaline
or dopamine (Färber et al., 2005). Further highlighting the role of
microglia in depression are the observations that antidepressants
like ketamine (Walker et al., 2013), fluoxetine (Chung et al., 2011)
or citalopram (Su et al., 2015) regulate microglia function and
minocycline, an inhibitor of microglia, simultaneously recovers
microglia function and emotional impairments (Hinwood et al.,
2013). Thus, the available evidence indicates that microglia
dysfunction is a core event in depression (Figure 1), affecting
synaptic plasticity either directly (Paolicelli et al., 2011; Zhan
et al., 2014) or indirectly through its ability to control astrocytic
function (Pascual et al., 2012).
INTEGRATIVE ROLE OF PURINES IN THE
QUAD-PARTITE SYNAPSE TO CONTROL
DEPRESSION
In view of the key role of aberrant synaptic plasticity involving
neuronal, astrocytic and microglia dysfunction (Figure 1),
therapeutic strategies to manage depression should ideally target
systems dedicated to the control of neuron-glia bidirectional
communication. Purines operate one such system through the
action of ATP and adenosine (Figure 2). ATP is released
in a controlled manner from synaptic terminals, astrocytes
and microglia and it is a documented signal to control
astrogliosis, microglia dynamics and reactivity and synaptic
transmission through ionotropic P2X1–7 and metabotropic
P2Y1–13 receptors (reviewed in Rodrigues et al., 2015).
Adenosine can be formed from the catabolism of extracellular
ATP (Augusto et al., 2013) by ectonucleotidases located in
synapses (Cunha, 2001) or released as such through bidirectional
nucleoside transporters in synapses (Pinto-Duarte et al., 2005).
Adenosine mainly activates inhibitory A1 and facilitatory A2A
FIGURE 2 | Purine-based control of glia-neuron bidirectional
communication in depression. Associated with astrocytic hypofunction in
depression, there is a lower release of ATP and adenosine from astrocytes
(Cao et al., 2013; Hines et al., 2013). This causes a deficient
astrocyte-to-neuron activation of P2X2 (ATP) receptors (Cao et al., 2013) and
a deficient activation of inhibitory adenosine A1 receptors in neurons (Serchov
et al., 2015), which density decreases upon chronic stress (Cunha et al.,
2006; Kaster et al., 2015). In parallel, there is an increased excitability
(increased noise), which bolsters the synaptic release of ATP (Cunha et al.,
1996), an up-regulation of synaptic adenosine A2A receptors (Cunha et al.,
2006; Batalha et al., 2013; Kaster et al., 2015), which is associated with
aberrant plasticity (Li et al., 2015), and an up-regulation of microglia P2X7
receptors, which contributes to microglia hyper-responsiveness upon
depression (Stokes et al., 2015). This illustrates the role of the purinergic
system in the control of the homeostasis of the quad-partite synapse and
shows that maladaptive changes in the purine neuromodulation system occur
upon depression that can be exploited therapeutically, such as increasing the
release of ATP and adenosine from astrocytes, decreasing the neuronal
activation of A2A receptor or bolstering the neuronal activation of A1 receptors
or inhibiting microglia P2X7 receptors.
receptors (Fredholm et al., 2005) that act neuronally to control
synaptic transmission and plasticity (Cunha, 2008) and also
control astrocytic (van Calker and Biber, 2005; Matos et al., 2013,
2015) and microglia function (Rebola et al., 2011; Luongo et al.,
2014; George et al., 2015).
Notably, both ATP and adenosine signaling have been
implicated in the control of depressive conditions (Figure 2).
Thus, a deficient astrocyte-derived ATP release providing
an insufficient P2X2 receptor-mediated neuronal tonus was
identified in chronically stressed mice (Cao et al., 2013); also,
the prevention of excessive P2X7 receptor activation in glial
cells ameliorates depressive-like conditions (Stokes et al., 2015)
and P2X7 receptor polymorphisms lead to vulnerability to
mood disorders (Bennett, 2007). The case for an involvement
of adenosine is more robust. Thus, epidemiological studies
show an inverse relation between the intake of moderate
amounts of caffeine (an adenosine receptor antagonist) and
the incidence of depression (Lucas et al., 2011) and suicide
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(Lucas et al., 2014). Accordingly, adenosine A2A receptors
are up-regulated in animal models of chronic stress and
polymorphisms of A2A receptors are associated with emotional
disturbances (reviewed in Cunha et al., 2008), their over-
expression triggers emotional dysfunction (Coelho et al.,
2014) and their blockade prevents chronic stress-induced
emotional dysfunction (Kaster et al., 2015). Additionally,
there is a hypofunction of neuronal A1 receptors due to
decrease astrocyte-derived adenosine (Hines et al., 2013), which
compensation with various antidepressant treatments can revert
depressive-like behavior (Etiévant et al., 2015; Serchov et al.,
2015).
This compilation of evidences illustrates the relevance
of the purinergic signaling in the control of neuron-glia
bidirectional communication and its therapeutic potential in the
normalization of aberrant synaptic processing in frontolimbic
circuits upon depression. Based on the available information,
the most promising strategy is a multi-target approach, based
on the increase of astrocytic release of purines (both ATP and
adenosine to activate A1 receptors) coupled to antagonists of
P2X7 and of A2A receptors (Figure 2).
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